Physician profile
Michael Didinsky
NPI 1316928336
$157,097.30
in general payments reported to CMS, 2019-2025
16 companies · $1,101 in 2025
The $1,101 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $39K · 2021: $33K · 2022: $25K · 2023: $3,892 · 2024: $5,072 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,150 · Travel and Lodging: $3,859 · Royalty Or License: $2,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,149.78 |
| Travel and Lodging | $3,858.53 |
| Royalty Or License | $2,057.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $145,688.44 | 2019-2025 | Caliber, Xlif, Tlif |
| Stryker Corporation | $5,508.23 | 2020-2025 | Bio4, Na, Everest Spinal System |
| Cerapedics INC. | $2,907.28 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $2,392.50 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $354.61 | 2023 | Magnetom Free.Max |
| Nevro Corp. | $42.04 | 2020-2022 | |
| Centinel Spine, LLC | $26.18 | 2023 | Prodisc C Vivo |
| Bioventus LLC | $24.99 | 2019 | |
| Zimvie INC. | $23.65 | 2023 | |
| Si-Bone, INC. | $22.43 | 2021 | |
| Depuy Synthes Sales INC. | $22.24 | 2020 | |
| Relievant Medsystems, INC. | $20.37 | 2022 | |
| Horizon Therapeutics Plc | $18.52 | 2019 | |
| Amgen INC. | $17.52 | 2021 | |
| Nuvasive, INC. | $17.28 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Didinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.